[1]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2012/238754,2012,A1
[1]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2012/238754,2012,A1
[1]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2012/238754,2012,A1
[1]Patent:US2012/238754,2012,A1.Locationinpatent:Paragraph0113;0114
Title: BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
Journal: Theranostics 20160101
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20121215
Title: Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology.
Journal: The oncologist 20090601
Title: BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090501
Title: Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis.
Journal: Molecular biology of the cell 20071001
Title: Polo-like kinases and the orchestration of cell division.
Journal: Nature reviews. Molecular cell biology 20040601
